---
title: "CEVIA released its performance for the first half of the year, with a net profit attributable to shareholders of 589 million yuan, a year-on-year increase of 20.15%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252481850.md"
description: "CEVIA released its semi-annual report for 2025, achieving operating revenue of 3.216 billion yuan during the reporting period, a year-on-year increase of 11.25%; net profit attributable to the parent company was 589 million yuan, a year-on-year increase of 20.15%; net profit excluding non-recurring gains and losses was 555 million yuan, a year-on-year increase of 14.82%; basic earnings per share were 0.9172 yuan"
datetime: "2025-08-11T11:26:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252481850.md)
  - [en](https://longbridge.com/en/news/252481850.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252481850.md)
generator: "portal-rs"
---

# CEVIA released its performance for the first half of the year, with a net profit attributable to shareholders of 589 million yuan, a year-on-year increase of 20.15%

According to the Zhitong Finance APP, CEVIA (000885.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 3.216 billion yuan, a year-on-year increase of 11.25%. The net profit attributable to shareholders of the listed company was 589 million yuan, a year-on-year increase of 20.15%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 555 million yuan, a year-on-year increase of 14.82%. The basic earnings per share were 0.9172 yuan

### Related Stocks

- [000885.CN](https://longbridge.com/en/quote/000885.CN.md)

## Related News & Research

- [REG - RentGuarantor Hldgs - TR-1: Notification of major holdings](https://longbridge.com/en/news/297805070.md)
- [Istanbul Care Unveils All-Inclusive 2026 Hair Transplant Packages Featuring Fixed Pricing and Individualized Clinical Care](https://longbridge.com/en/news/297951968.md)
- [REG - CQS New City HighYld - Issue of Equity](https://longbridge.com/en/news/297806512.md)
- [02:00 ETArgo Biopharma to Present Positive Phase II Updated Results of siRNA Therapeutic BW-20805 for HAE at Bradykinin Symposium 2026](https://longbridge.com/en/news/297995914.md)
- [WHL: Revenue up 4.3% to R83.5bn, profit before tax R3.2bn, final dividend 81.0c per share](https://longbridge.com/en/news/297735422.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**